247 related articles for article (PubMed ID: 26352932)
1. Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.
Abulaihaiti M; Wu XW; Qiao L; Lv HL; Zhang HW; Aduwayi N; Wang YJ; Wang XC; Peng XY
PLoS Negl Trop Dis; 2015; 9(9):e0003950. PubMed ID: 26352932
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of albendazole chitosan microspheres against Echinococcus granulosus infection in mice].
Liang W; Wang XC; Wu XW; Zhang SJ; Sun H; Ma X; Peng XY
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2014 Jun; 32(3):188-92. PubMed ID: 25223052
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of albendazole in combination with thymol against Echinococcus multilocularis protoscoleces and metacestodes.
María AC; Celina EM
Acta Trop; 2014 Dec; 140():61-7. PubMed ID: 25149355
[TBL] [Abstract][Full Text] [Related]
4. In vivo activity of albendazole in combination with thymol against Echinococcus multilocularis.
Albani CM; Pensel PE; Elissondo N; Gambino G; Elissondo MC
Vet Parasitol; 2015 Sep; 212(3-4):193-9. PubMed ID: 26190130
[TBL] [Abstract][Full Text] [Related]
5. Albendazole nanocrystals in experimental alveolar echinococcosis: Enhanced chemoprophylactic and clinical efficacy in infected mice.
Pensel P; Paredes A; Albani CM; Allemandi D; Sanchez Bruni S; Palma SD; Elissondo MC
Vet Parasitol; 2018 Feb; 251():78-84. PubMed ID: 29426481
[TBL] [Abstract][Full Text] [Related]
6. Novel albendazole-chitosan nanoparticles for intestinal absorption enhancement and hepatic targeting improvement in rats.
Liu Y; Wang XQ; Ren WX; Chen YL; Yu Y; Zhang JK; Bawudong D; Gu JP; Xu XD; Zhang XN
J Biomed Mater Res B Appl Biomater; 2013 Aug; 101(6):998-1005. PubMed ID: 23529958
[TBL] [Abstract][Full Text] [Related]
7. Development of an injectable formulation of albendazole and in vivo evaluation of its efficacy against Echinococcus multilocularis metacestode.
Rodrigues JM; Bories C; Emery I; Fessi H; Devissaguet JP; Liance M
Int J Parasitol; 1995 Dec; 25(12):1437-41. PubMed ID: 8719955
[TBL] [Abstract][Full Text] [Related]
8. Effect of treatment with free and liposomized albendazole on selected immunological parameters and cyst growth in mice infected with Echinococcus multilocularis.
Dvoroznáková E; Hrcková G; Borosková Z; Velebný S; Dubinský P
Parasitol Int; 2004 Dec; 53(4):315-25. PubMed ID: 15464441
[TBL] [Abstract][Full Text] [Related]
9. Albendazole increases the inflammatory response and the amount of Em2-positive small particles of Echinococcus multilocularis (spems) in human hepatic alveolar echinococcosis lesions.
Ricken FJ; Nell J; Grüner B; Schmidberger J; Kaltenbach T; Kratzer W; Hillenbrand A; Henne-Bruns D; Deplazes P; Moller P; Kern P; Barth TFE
PLoS Negl Trop Dis; 2017 May; 11(5):e0005636. PubMed ID: 28542546
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the efficacy of albendazole sulfoxide (ABZ-SO)-loaded chitosan-PLGA nanoparticles in the treatment of cystic echinococcosis in laboratory mice.
Darvishi MM; Moazeni M; Alizadeh M; Abedi M; Tamaddon AM
Parasitol Res; 2020 Dec; 119(12):4233-4241. PubMed ID: 32996050
[TBL] [Abstract][Full Text] [Related]
11. Augmented bioavailability and cysticidal activity of albendazole reformulated in soybean emulsion in mice infected with Echinococcus granulosus or Echinococcus multilocularis.
Shuhua X; Jiqing Y; Mingjie W; Pieying J; Fanghua G; Junjie C; Wei J; Hotez P
Acta Trop; 2002 Apr; 82(1):77-84. PubMed ID: 11904106
[TBL] [Abstract][Full Text] [Related]
12. Albendazole solid dispersions against alveolar echinococcosis: a pharmacotechnical strategy to improve the efficacy of the drug.
Fabbri J; Pensel PE; Albani CM; Lopez LM; Simonazzi A; Bermudez JM; Palma SD; Elissondo MC
Parasitology; 2020 Aug; 147(9):1026-1031. PubMed ID: 32338226
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology and efficacy of liposome-entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine.
Wen H; New RR; Muhmut M; Wang JH; Wang YH; Zhang JH; Shao YM; Craig PS
Parasitology; 1996 Aug; 113 ( Pt 2)():111-21. PubMed ID: 8760312
[TBL] [Abstract][Full Text] [Related]
14. Cystic echinococcosis therapy: Albendazole-loaded lipid nanocapsules enhance the oral bioavailability and efficacy in experimentally infected mice.
Pensel PE; Ullio Gamboa G; Fabbri J; Ceballos L; Sanchez Bruni S; Alvarez LI; Allemandi D; Benoit JP; Palma SD; Elissondo MC
Acta Trop; 2015 Dec; 152():185-194. PubMed ID: 26409727
[TBL] [Abstract][Full Text] [Related]
15. Albendazole treatment in cystic echinococcosis: pharmacokinetics and clinical efficacy of two different aqueous formulations.
Ceballos L; Elissondo C; Moreno L; Dopchiz M; Sánchez Bruni S; Denegri G; Alvarez L; Lanusse C
Parasitol Res; 2008 Jul; 103(2):355-62. PubMed ID: 18465143
[TBL] [Abstract][Full Text] [Related]
16. Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity.
Stettler M; Rossignol JF; Fink R; Walker M; Gottstein B; Merli M; Theurillat R; Thormann W; Dricot E; Segers R; Hemphill A
Int J Parasitol; 2004 Apr; 34(5):615-24. PubMed ID: 15064126
[TBL] [Abstract][Full Text] [Related]
17. Impact of Albendazole on Cytokine and Chemokine Response Profiles in
Wu J; Ma HZ; Apaer S; Anweier N; Zeng Q; Fulati X; Li T; Zhao JM; Wen H; Tuxun T
Biomed Res Int; 2021; 2021():6628814. PubMed ID: 34041299
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro efficacy of crocin against Echinococcus multilocularis.
Liu C; Fan H; Guan L; Ge RL; Ma L
Parasit Vectors; 2021 Jul; 14(1):364. PubMed ID: 34256821
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes.
Spicher M; Naguleswaran A; Ortega-Mora LM; Müller J; Gottstein B; Hemphill A
Exp Parasitol; 2008 Aug; 119(4):475-482. PubMed ID: 18442817
[TBL] [Abstract][Full Text] [Related]
20. In vivo efficacy of combination therapy with albendazole and atovaquone against primary hydatid cysts in mice.
Enkai S; Kouguchi H; Inaoka DK; Irie T; Yagi K; Kita K
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1815-1820. PubMed ID: 33770336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]